- The $35 billion vaccine market is dominated by GlaxoSmithKline, Sanofi Adventis, Merck and Pfizer.
- These 4 players represent 85% of the vaccine market.
This Small Elite Group Made Millions From Coronavirus
While the outbreak has claimed more than 3000 lives officially, this small elite group made millions from Coronavirus, courtesy of their association with the biotechs working on Coronavirus
The $35 billion vaccine market is dominated by GlaxoSmithKline, Sanofi Adventis, Merck and Pfizer. These 4 players represent 85% of the vaccine market. These are the primary players but are by no means alone because there is a global rush out there.
Three biotech stocks are surging on the possibility of coronavirus drugs and minting millions of dollars for their biggest shareholders. Gilead, Moderna, and Novavax have all outperformed the falling stock market in recent days as the three drug developers rush to introduce preventative vaccines and treatments.
Here are the seven venture capitalists, scientists, and executives who made millions from the surging biotechs, ranked in ascending order of gains. Profit data is calculated from each stock’s gains from February 21 to February 26, according to Markets Insider.
EXCLUSIVE#Coronavirus Bioweapon Thread
How China Stole Coronavirus From Canada And Weaponized Itgreatgameindia.com/coronavirus-bi…
785 people are talking about this
Novavax
Novavax Inc has a proprietary nanoparticle technology that uses different antigens to give the patient better immune response. This broader response could result in a superior vaccine with a level of adaptability built into the vaccine. The company quickly developed a COVID-19 vaccine candidate and has a track record of vaccine development especially for the MERS and SARS strains. After Novavax revealed the development and animal testing of its own vaccine, its shares leaped 19.4%, making its investors richer by millions.
Stanley Erck
Shares held: 46,776
Gain: $70,164
About: Erck served as Novavax’s CEO since April 2011.
Rajiv Modi
Shares held: 125,000
Gain: $187,500
About: Modi worked as managing director of Cadila Pharmaceuticals when the firm took an $11 million stake in Novavax in April 2009. He’s served on Novavax‘s board of directors since the joint venture’s announcement.
Gilead
Drug developer Gilead shares soared to 16-month high after WHO official said its experimental treatment is best shot for fighting coronavirus. The company soared as much as 6.9% after the open before paring some gains. The jump pushed Gilead’s shares to their highest level since October 2018. Gilead’s stock is up roughly 13% in February, surging on investor hopes that its treatment can be the first to curb the coronavirus outbreak, but experts doubt whether Gilead’s Remdesivir can treat Coronavirus.
John Milligan
Shares held: 1,574,306
Gain: $7,871,530
About: Milligan served as Gilead’s CEO from March 2016 to July 2018.
John Martin
Shares held: 2,887,225
Gain: $14,436,125
About: Martin served as Gilead’s CEO from 1996 to 2016.
Moderna
After Moderna shipped the first coronavirus vaccine for human testing, its shares surged as much as 22%. The firm submitted vials of mRNA-1273 to the National Institute of Allergy and Infectious Diseases for a phase one study in the US, according to a press release. Moderna is the first company to push a preventative vaccine for the outbreak to trial.
Timothy Springer
Shares held: 4,272,968
Gain: $46,703,540
About: Springer works as an immunologist at Harvard Medical School and invested $5 million in Moderna early in the company’s history. The Harvard professor made $400 million from Coronavirus vaccine.
Stephane Bancel
Shares held: 7,456,986
Gain: $81,504,857
About: Bancel has served as Moderna’s CEO since October 2011 and previously worked for French diagnostics firm bioMérieux as its chief executive.
Robert Langer
Shares held: 11,509,537
Gain: $125,799,239
About: Langer sits on Moderna’s board of directors and serves as a professor at MIT. He joined Moderna as an academic co-founder.
For latest updates on the outbreak check out our Coronavirus Coverage. Join us on WhatsApp for more intel and updates.
- EXCLUSIVE: Coronavirus Bioweapon – How China Stole Coronavirus From Canada And Weaponized It
- ASSASSINATION: Key Coronavirus Investigation Scientist Frank Plummer Assassinated
- INTERVIEW: Dr. Francis Boyle Creator Of BioWeapons Act Says Coronavirus Is Biological Warfare Weapon
- CENSORED: Were Coronavirus Samples Destroyed By China To Coverup The Outbreak?
- Chinese Biological Warfare Agent: Dr. Xiangguo Qiu
- Bio-Espionage: Chinese Researchers Caught Stealing Coronavirus From Canadian Lab
- Bio-Espionage: Chinese Biowarfare Agents At Harvard University Caught Smuggling Viruses
- GGI IMPACT: White House To Investigate If Coronavirus Was Weaponized
- INVESTIGATION: India To Investigate Wuhan Institute Of Virology
- BOOK: Wuhan-400 Coronavirus – 1981 Novel Predicts Virus Origin
- Scientific Investigation On Mysterious Origin Of Coronavirus: COVID19 Files
- TOP SECRET: China’s Secret Plan To Weaponize Viruses
- Taiwan Intelligence: SARS – A Chinese Bioweapon
- Bio-Warfare: Weaponizing Biotech – China’s War for Biological Dominance
- Bio-Warfare: Rise Of China’s Biological Warfare Program
- STUDY: Indian Scientists Discover Coronavirus Engineered With HIV Like Insertions
- VACCINE: The $35 Billion Vaccine Market
- VACCINE: China Using HIV Drugs For Coronavirus Treatment
- DIAGNOSIS: CT Scan – Best Diagnosis For Coronavirus
- Bio-Espionage: Canada Investigates China’s Biological Espionage
- Epicentre Of Coronavirus: Wuhan Institute Of Virology
- BOMBSHELL REPORT: How Coronavirus Leaked From Wuhan Laboratory
- China’s P4 Lab: How China France Alliance Created Wuhan’s Bioweapons Laboratory
- Shincheonji Church: Secret Cult Linked To Coronavirus Outbreak In South Korea
- Exclusive Interview Of Former Virologist: Coronavirus Coverup
- Bioweapons Expert Dr. Francis Boyle On Coronavirus: TRANSCRIPT
- Coronavirus Origin: US Senator Tom Cotton Questions Mainstream Media’s Narrative
- Caixin Report: Tracking The Source Of New Coronavirus Gene Sequencing
- STUDY: Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag
- STUDY: A novel coronavirus capable of lethal human infections: an emerging picture
- VACCINE: Biotechs Working On Coronavirus Vaccine
- VACCINE: Can Gilead’s Remdesivir Treat Coronavirus?
- VACCINE: Washington Pledges $1 Billion For Coronavirus Vaccine
- VACCINE: Moderna Coronavirus Vaccine Ready For Human Testing
- VACCINE: How A Harvard Professor Made $400 Million From Coronavirus Vaccine
- VACCINE: This Small Elite Group Made Millions From Coronavirus
GreatGameIndia is a journal on Geopolitics and International Relations. Get to know the Geopolitical threats India is facing in our exclusive book India in Cognitive Dissonance. Past magazine issues can be accessed from the Archives section.
Read more on Chinese Biological and Chemical warfare activities against India in our exclusive History of Narco-Terrorism issue.
Send in your tips and submissions by filling out this form or write to us directly at the email provided. Join us on WhatsApp for more intel and updates.
We need your support to carry on our independent and investigative research based journalism on the external and internal threats facing India. Your contribution however small helps us keep afloat. Kindly consider donating to GreatGameIndia.
___
Ei kommentteja:
Lähetä kommentti
You are welcome to show your opinion here!